Literature DB >> 8201776

Cardiac pheochromocytoma. A case report and review of the literature.

T Gomi1, T Ikeda, J Sakurai, Y Toya, M Tani.   

Abstract

A case of intrapericardial pheochromocytoma which secreted predominantly norepinephrine is reported. A tumor at the posterior wall of the left atrium was demonstrated by computed tomographic and magnetic resonance imaging scan. Tumor blush arising from the left circumflex branch was visualized by coronary angiography. The tumor (4 x 3.5 x 2 cm) was resected with adherent atrial wall and the defect reconstructed with the patients own pericardium under general anesthesia with artificial cardiopulmonary bypass. His subsequent postoperative recovery was uneventful. At the time of discharge, 8 weeks after operation, his blood pressure and plasma norepinephrine remained normal. The value of magnetic resonance imaging scan for the topographic diagnosis of cardiac pheochromocytoma is emphasized.

Entities:  

Mesh:

Year:  1994        PMID: 8201776     DOI: 10.1536/ihj.35.117

Source DB:  PubMed          Journal:  Jpn Heart J        ISSN: 0021-4868


  4 in total

Review 1.  How does knowledge of the blood supply to an intracardiac tumour help?

Authors:  Prabha Nini Gupta; Nishant Sagar; Ritesh Ramachandran; Velenurre Rajagopalan Rajeshekharan
Journal:  BMJ Case Rep       Date:  2019-02-25

2.  Surgical excision of malignant pheochromocytoma in the left atrium.

Authors:  K Nonaka; H Makuuchi; Y Naruse; T Kobayashi; M Goto
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-02

3.  A primary right atrium paraganglioma in a 15-year-old patient.

Authors:  Wen-Qi Yuan; Wei-Qinq Wang; Ting-Wei Su; Hai-Tao Chen; Zhong-Wei Shi; Wen-Qiang Fang; Biao Li; Xiao-Long Jin; Wang-Fu Zang; Guang Ning
Journal:  Endocrine       Date:  2007-11-28       Impact factor: 3.633

Review 4.  Management of hypertension in intrapericardial paraganglioma.

Authors:  Nicola Rotolo; Andrea Imperatori; Alessandro Bacuzzi; Valentina Conti; Massimo Castiglioni; Lorenzo Dominioni
Journal:  Int J Hypertens       Date:  2014-02-13       Impact factor: 2.420

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.